Clinical Trial Update: Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Adebrelimab in combination with chemoradiotherapy followed by Adebrelimab maintenance for limited-stage small-cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Limited-stage Small-cell Lung Cancer, Concurrent Chemoradiation Therapy | Phase 2 | Status: NOT_YET_RECRUITING